Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein
dc.authorid | Demir, Serkan/0000-0003-4395-5141 | |
dc.authorid | GUNGOR, SERDAL/0000-0003-3875-6770 | |
dc.authorid | Demirci, Serpil/0000-0003-1561-1296 | |
dc.contributor.author | Koc, Sumeyye | |
dc.contributor.author | Sen, Sedat | |
dc.contributor.author | Terzi, Yuksel | |
dc.contributor.author | Kizilay, Ferah | |
dc.contributor.author | Demir, Serkan | |
dc.contributor.author | Aksoy, Durdane Bekar | |
dc.contributor.author | Kurtulus, Fatma | |
dc.date.accessioned | 2025-02-22T14:08:38Z | |
dc.date.available | 2025-02-22T14:08:38Z | |
dc.date.issued | 2024 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Background: Optic neuritis, myelitis, and neuromyelitis optica spectrum disorder (NMOSD) have been associated with antibodies against myelin oligodendrocyte glycoprotein-immunoglobulin G (anti-MOG-IgG). Furthermore, patients with radiological and demographic features atypical for multiple sclerosis (MS) with optic neuritis and myelitis also demonstrate antibodies against aquaporin-4 and anti-MOG-IgG. However, data on the diagnosis, treatment, follow-up, and prognosis in patients with anti-MOG-IgG are limited. Aims: To evaluate the clinical, radiological, and demographic characteristics of patients with anti-MOG-IgG. Study Design: Multicenter, retrospective, observational study. Methods: Patients with blood samples demonstrating anti-MOG-IgG that had been evaluated at the Neuroimmunology laboratory at Ondokuz May & imath;s University's Faculty of Medicine were included in the study. Results: Of the 104 patients with anti-MOG-IgG, 56.7% were women and43.3% were men. Approximately 2.4% of the patients were diagnosed with MS, 15.8% with acute disseminated encephalomyelitis (ADEM), 39.4% with NMOSD, 31.3% with isolated optic neuritis, and 11.1% with isolated myelitis. Approximately 53.1% of patients with spinal involvement at clinical onset demonstrated a clinical course of NMOSD. Thereafter, 8.8% of these patients demonstrated a clinical course similar to MS and ADEM, and 28.1% demonstrated a clinical course of isolated myelitis. The response to acute attack treatment was lower and the disability was higher in patients aged > 40 years than patients aged < 40 years at clinical onset. Oligoclonal band was detected in 15.5% of the patients. Conclusion: For patients with NMOSD and without anti-NMO antibodies, the diagnosis is supported by the presence of anti-MOG-IgG. Furthermore, advanced age at clinical onset, Expanded Disability Status Scale (EDSS) score at clinical onset, spinal cord involvement, and number of attacks may be negative prognostic factors in patients with anti-MOG-IgG. | en_US |
dc.identifier.doi | 10.4274/balkanmedj.galenos.2024.2024-1-97 | |
dc.identifier.endpage | 279 | en_US |
dc.identifier.issn | 2146-3123 | |
dc.identifier.issn | 2146-3131 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 38828767 | en_US |
dc.identifier.scopus | 2-s2.0-85197994337 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 272 | en_US |
dc.identifier.trdizinid | 1273590 | en_US |
dc.identifier.uri | https://doi.org/10.4274/balkanmedj.galenos.2024.2024-1-97 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1273590 | |
dc.identifier.uri | https://hdl.handle.net/11468/29532 | |
dc.identifier.volume | 41 | en_US |
dc.identifier.wos | WOS:001267760500006 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | TR-Dizin | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Galenos Publ House | en_US |
dc.relation.ispartof | Balkan Medical Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | KA_WOS_20250222 | |
dc.subject | Mog | en_US |
dc.subject | Adults | en_US |
dc.title | Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein | en_US |
dc.type | Article | en_US |